Figshareopen access

Health impact and cost-effectiveness analysis of introducing a national immunization program with 21-valent versus 20-valent pneumococcal conjugate vaccines for adults ≥65 years of age in Denmark

Name: Health impact and cost-effectiveness analysis of introducing a national immunization program with 21-valent versus 20-valent pneumococcal conjugate vaccines for adults ≥65 years of age in Denmark
License: Open Access

Oluwaseun Sharomi (19645339) et al.

Figshare · Datasets · License: Open Access

Open Source ↗

cancer medicine

medicine, microbiology, sociology, immunology, cancer, science policy, infectious diseases, computational biology

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 357085
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.